Molecular Partners AG Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | $1.43 | $1.43 | $1.43 |
| Q2 2024 | 1 | $1.20 | $1.20 | $1.20 |
| Q3 2024 | 1 | -$0.53 | -$0.53 | -$0.53 |
| Q4 2024 | 1 | -$0.38 | -$0.38 | -$0.38 |
Molecular Partners AG Earnings Date And Information
Molecular Partners AG last posted its earnings results on Thursday, October 31st, 2024. The company reported $-0.57 earnings per share for the quarter, topping analysts' consensus estimates of $-0.63 by $0.06. The company had revenue of 681,000 for the quarter and had revenue of 7.04 M for the year. Molecular Partners AG has generated $-2 earnings per share over the last year ($-1.89 diluted earnings per share) and currently has a price-to-earnings ratio of -2.57. Molecular Partners AG has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 6th, 2025 based on prior year's report dates.
Molecular Partners AG Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 09/30/2024 | Q3 2024 | -$0.49 | $349,065 | $681,000 | ||
| 06/28/2024 | Q2 2024 | -$0.45 | $795,745 | $1.55 M | ||
| 05/17/2024 | Q1 2024 | -$0.34 | $2.74 M | |||
| 03/14/2024 | Q4 2023 | -$0.97 | -$0.60 | 0.37 | $1.03 M | |
| 09/30/2023 | Q3 2023 | -$0.35 | $1.40 M | $2.54 M | ||
| 05/12/2023 | Q2 2023 | -$0.49 | $1.60 M | $415,000 | ||
| 05/12/2023 | Q1 2023 | -$0.47 | $3.05 M | |||
| 03/09/2023 | Q4 2022 | $0.90 | -$0.55 | -1.45 | $2.69 M | |
| 09/29/2022 | Q3 2022 | -$0.37 | $3.27 M | $2.34 M | ||
| 08/31/2022 | Q2 2022 | -$0.08 | $11.72 M | $11.75 M | ||
| 08/31/2022 | Q1 2022 | $4.74 | $172.78 M | |||
| 03/15/2022 | Q4 2021 | -$1.04 | -$0.55 | 0.49 | $1.78 M | |
| 09/30/2021 | Q3 2021 | -$0.38 | $2.03 M | $3.53 M | ||
| 06/30/2021 | Q2 2021 | -$0.53 | $2.02 M | $3.21 M | ||
| 03/31/2021 | Q1 2021 | -$0.57 | $815,000 | |||
| 12/31/2020 | Q4 2020 | -$0.74 | $1.55 M | |||
| 09/30/2020 | Q3 2020 | -$0.60 | $283,000 | |||
| 06/29/2020 | Q2 2020 | -$0.52 | $13.61 M | $3.71 M | ||
| 03/30/2020 | Q1 2020 | -$0.62 | $3.81 M | |||
| 12/30/2019 | Q4 2019 | -$0.55 | $3.42 M |
Molecular Partners AG Earnings: Frequently Asked Questions
-
When is Molecular Partners AG's earnings date?
Molecular Partners AG has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 6th, 2025 based off last year's report dates.
-
Did Molecular Partners AG beat their earnings estimates last quarter?
In the previous quarter, Molecular Partners AG (:MOLN) reported $-0.57 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.63 by $0.06.
-
How can I listen to Molecular Partners AG's earnings conference call?
The conference call for Molecular Partners AG's latest earnings report can be listened to online.
-
How can I read Molecular Partners AG's conference call transcript?
The conference call transcript for Molecular Partners AG's latest earnings report can be read online.
-
How much revenue does Molecular Partners AG generate each year?
Molecular Partners AG (:MOLN) has a recorded annual revenue of $7.04 M.
-
How much profit does Molecular Partners AG generate each year?
Molecular Partners AG (:MOLN) has a recorded net income of $7.04 M. Molecular Partners AG has generated $-1.89 earnings per share over the last four quarters.
-
What is Molecular Partners AG's price-to-earnings ratio?
Molecular Partners AG (:MOLN) has a price-to-earnings ratio of -2.57 and price/earnings-to-growth ratio is 0.32.
